By Mike Ward
Editor, Europe

OXFORD - Britain's biotech sector breathed a collective sigh of relief when the U.K. government announced last week that it had no intention of introducing new legislation to regulate the industry in the aftermath of the Millargate affair at British Biotech plc. Instead, the government said it welcomes the U.K. BioIndustry Association's proposal to develop and introduce a code of best practice for the biotech sector.